Category: NEWLY PUBLISHED
Drug Innovation: FDA Approves Seven New Drugs in Four Months (Jan-Apr 2018)
Within first four months of 2018, seven new drugs are already approved by the FDA for a wide range of diseases including HIV, psoriasis, and rare cancers. 2018 will also see the first ever “game-changing” CRISPR gene editing clinical trial in humans.
AI-Based Pharma Startup BenevolentAI worth $2 Billion Raises $115 M Funding
UK-based BenevolentAI raised one of the largest fundings in AI pharmaceutical field. The company is significantly disrupting the pharma industry which spends $180 billion in a year on R&D.
AstraZeneca Commits $90 Million in 5 Years to Improve Healthcare in India
Over the next five years, pharma giant, AstraZeneca will invest $90 million in India to improve the overall health outcomes in the country, by promoting innovation, skill development, and quality manufacturing.
Genprex Raises $6.4 M in IPO, Could Bring “Game-Changing” Immuno-Gene Therapy for Advanced Lung Cancer
Genprex raised $6.4 million in IPO at a share price of $5. Unlike most of the commercial blockbuster lung cancer immunotherapies, its unique lead candidate, Oncoprex® targets advanced lung cancer treatment.
Pharma Giants Gradually Embracing Digital Healthcare Technologies
Big pharma players including Novartis, Roche, Pfizer, Sanofi are embracing digital technologies to deliver better to the patients. FDA’S 2018 Strategic Policy Roadmap indicates increasing number of digital health clearances in coming times with revised regulatory processes.
First-of-its-Kind FDA-Cleared Device Launched to Enhance Tear Production
Allergan has launched the first and the only FDA-cleared device TrueTear® to temporarily increase tear production in adult patients with inadequate tear production.
Delhi-Based Healthcare Fintech Startup Raises $1 M in Seed Funding Round
Delhi-based healthcare financing startup, LetsMD has raised $1 million a pre-series A funding round led by SRI Capital.
First AI-Based Diabetic Retinopathy Detection Device Gets FDA Approval
The artificial intelligence (AI) based device called IDx-DR received US FDA approval for the screening of diabetic retinopathy- a common eye disease in diabetic patients that could lead to vision impairment and blindness.
AI–Based Nutrition Analytics Startup, Nutrino Raises $8 M in Series A Funding
Israeli startup Nutrino raised $8 million in their Series A funding round led by the existing investor New York Angels. According to the Medgenera report, the investment funding in health analytics is estimated to reach around $4.4 billion in 2018 at about 65.7% CAGR during 2015-2018.
Is Novartis Betting High to Give First FDA-Approved Gene Therapy for Spinal Muscular Atrophy?
Novartis bets high by acquiring the non-earning US-based gene therapy firm AveXis for $8.7 billion. But, AveXis' novel gene therapy- AVXS-101 could be a “game-changing” treatment for SMA patients and could turn out to be a potential blockbuster for Novartis, if approved.